Skip to main content

Eden Research to use Polish approval for Mevalone as springboard into central Europe

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Eden Research PLC (AIM:EDEN, OTCQB:EDNSF) CEO Sean Smith speaks to Proactive after announcing that the company's flagship bio-fungicide Mevalone has been approved for use by Polish regulators.

Smith says that the authorisation in Poland is just the beginning of a cascading process that will continue into adjacent European Union member states as well as the United Kingdom.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  258.51
-0.39 (-0.15%)
AAPL  319.97
-8.24 (-2.51%)
AMD  477.57
+21.41 (4.69%)
BAC  62.68
-0.04 (-0.06%)
GOOG  335.31
-3.77 (-1.11%)
META  616.77
+6.09 (1.00%)
MSFT  499.70
-10.42 (-2.04%)
NVDA  230.36
+1.91 (0.84%)
ORCL  158.78
+4.74 (3.08%)
TSLA  354.08
-22.29 (-5.92%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.